Why Do I Keep Getting BV? A Recurrence Plan With the Numbers
In this article
- Why do I keep getting BV?
- How often does BV come back after treatment?
- What triggers the recurrence? The numbers
- Does my partner need antibiotics too? The 2025 couples trial
- What does the NHS offer if BV comes back more than four times a year?
- Where do live cultures fit, and what do the trials show?
- A recurrence plan in the order women live it
- What we don't know
- Frequently asked questions
BV keeps coming back because antibiotics clear the overgrowth but do not restore the lactobacilli that keep the vagina acidic, and because the triggers carry on: in a cohort of 139 women followed for a year after a standard course, BV returned in 58%.1 The triggers are measured: a period roughly doubles the chance of an episode, sex with the same partner raises recurrence 1.9-fold, the copper coil 1.28-fold, and oestrogen-containing contraception halves it.2, 3, 4 Antibiotics for the male partner cut recurrence from 63% to 35% in a 2025 trial, the NHS offers a months-long vaginal antibiotic gel for more than four episodes a year, and in ten trials of 1,234 women live cultures taken after antibiotics were associated with recurrence of 14.8% against 25.5%.5, 6, 7 What is the main cause of BV explains the condition itself.
Sources checked on 29 October 2026.
Why do I keep getting BV?
The antibiotics act on the anaerobes that have overgrown, not on what let them overgrow: a healthy vagina is dominated by lactobacilli, which make lactic acid and hold the pH at around 3.5, and BV is the loss of that dominance.8 If the lactobacilli that return after a course are the less protective kind, the vagina sits close to the tipping point again.2 And the triggers do not stop: periods, semen, a copper coil, douching, perfumed products and smoking are all linked to BV, most through a less acidic vagina.
How often does BV come back after treatment?
Often. In the best-known cohort, 139 women had a standard week of oral metronidazole and were followed for twelve months: BV recurred in 58%, and abnormal flora of some degree in 69%.1 In a 450-woman trial, recurrence was 28% at six months whatever was added to the antibiotic.3
What triggers the recurrence? The numbers
Ratios above 1 raise the risk; below 1 lower it.
| Trigger | Measured effect | Where measured |
|---|---|---|
| A period in the previous 24 hours | Onset of an episode doubled (adjusted hazard ratio 2.09) | Daily-sampling cohort, 100 women2 |
| Sex with the same regular partner after the course | Recurrence 1.9-fold | 450-woman trial3 |
| Inconsistent condom use | Recurrence 1.9-fold | Same trial3 |
| Oestrogen-containing contraception | Recurrence halved (0.5) | Same trial3 |
| Copper coil (IUD) | Risk 1.28-fold overall, 1.52-fold in the first six months | Cohort4 |
| Douching | Episode half as likely to clear on its own (0.45) among women whose flora was dominated by Lactobacillus iners, within 72 hours of douching | Same cohort2 |
| Smoking | On the NHS list of things not to do | NHS6 |
Does my partner need antibiotics too? The 2025 couples trial
If your partner is a woman or has a vagina, the NHS says they may need treatment as well.6 For male partners the evidence changed in 2025. Earlier trials gave men a week of oral antibiotics alone and found nothing, as did a 2016 Cochrane review of seven of them.9 Then a New England Journal of Medicine trial of 164 monogamous couples gave the man oral antibiotics plus an antibiotic cream for the penile skin for a week: BV returned in 35% of women within twelve weeks, against 63% when the woman alone had antibiotics.5 A 2026 network meta-analysis put the pooled reduction at about a quarter (incidence rate ratio 0.76).10 Ask at a sexual health clinic, which can prescribe for both of you; can a man give a woman BV? explains what is exchanged.
What does the NHS offer if BV comes back more than four times a year?
A suppressive course: the NHS says you may be given an antibiotic gel to use in the vagina for a few months.6 Metronidazole gel is prescription-only in the UK. Expect a swab first: is it thrush, BV or something else? has the decision table. Many sexual health clinics run a walk-in service; a GP can arrange the suppressive course; fever or pelvic pain with the discharge needs same-day care. How is BV treated in the UK? covers each antibiotic.
Where do live cultures fit, and what do the trials show?
After the antibiotics, not instead of them. In a 2022 meta-analysis of ten randomised trials with 1,234 women, those who took live cultures after a course of antibiotics had a BV recurrence rate of 14.8%, against 25.5% without them (relative risk 0.55); route, dose, duration and number of species made no difference.7 The order matters: in a 228-woman trial of a vaginal Lactobacillus crispatus biotherapeutic (a prescription-track product, not a supplement) given after metronidazole gel, recurrence by week twelve was 30% against 45%, and the benefit appeared only in women whose antibiotics had worked first.11, 12 Not every analysis agrees: a 2026 meta-analysis of eight trials of lactobacillus vaginal tablets found no significant effect (relative risk 0.86), while the network meta-analysis found that both vaginal and oral live cultures taken after antibiotics reduced early recurrence (relative risk 0.37 and 0.45; moderate and low certainty), with oral live cultures the most effective long-term option at low baseline risk (incidence rate ratio 0.49).10, 13 High-dose vitamin D did not reduce recurrence in a blinded trial of 118 women.14
The recurrence figures above come from trials of a range of strains and are reported here as evidence for live cultures after a course of antibiotics, not as a result for any one product. No live-culture product in Great Britain carries an authorised health claim. Anyone immunocompromised, seriously ill or with a central line should review live cultures with a pharmacist or GP first.
A recurrence plan in the order women live it
BV is not permanent; what feels permanent is recurrence, because the flora and the triggers have not changed.1
- Get the diagnosis confirmed. A swab at a sexual health clinic or GP; a first episode, pregnancy, fever or pelvic pain always need one. Burning when you pee is a urinary infection, which follows the same pattern for UTIs on its own page.
- Finish the course, and go back if it has not worked. Symptoms still there when it ends: return.
- Change the measured triggers. Condoms for two to three months as a test; no douching or perfumed products; stop smoking; raise a copper coil, and oestrogen-containing contraception, with your contraception clinic.3, 4
- Ask about your partner. A female partner may need antibiotics too; for a male partner, the 2025 trial cut recurrence from 63% to 35%.5
- More than four episodes a year: ask for the suppressive course. Months of vaginal antibiotic gel on the NHS, with a swab first.6
- Live cultures after the course, as the trials did. Ten trials, 1,234 women, 14.8% against 25.5%; after the antibiotics, never instead.7
What we don't know
Which live-culture strain, route and dose matter: the meta-analyses above disagree, and the trials tested different products.7, 13 Whether male-partner treatment holds outside one open-label trial that was stopped early.5 Why oestrogen-containing contraception halves recurrence: the finding is observational, not from a trial of contraception.3
Frequently asked questions
How can I stop BV coming back?
The NHS prevention list: wash the genital area with water and plain soap, have showers instead of baths, and do not use perfumed soaps, bubble bath, shampoo or shower gel in the bath, vaginal deodorants, washes or douches, antiseptic liquids in the bath or strong detergents on underwear; do not smoke.6 The measured additions are in the plan above: condoms for a few months as a test, a conversation about a copper coil, oestrogen-containing contraception, and live cultures after the course.3, 4, 7
What counts as recurrent BV?
The NHS threshold is more than four episodes in a year; at that point you may be given an antibiotic gel to use for a few months.6 BV was back in 58% of 139 women within twelve months, and the NHS says it usually returns within a few months.1, 6 A swab before each repeat course matters, because recurrent "BV" that never responds is sometimes thrush or trichomoniasis alongside it.
Is my coil causing my BV?
A copper coil raises the risk by about 1.28-fold, most in the first six months, and who is most likely to get BV has the figures and the other risk groups.4
What kills BV for good?
Nothing has been shown to end BV permanently in one go. Antibiotics clear each episode; the measured reductions in recurrence are partner antibiotics (63% to 35%), oestrogen-containing contraception (halved) and live cultures after antibiotics (25.5% to 14.8%).3, 5, 7
Sources
- Bradshaw CS, et al. High recurrence rates of bacterial vaginosis 12 months after oral metronidazole therapy. Journal of Infectious Diseases, 2006. Prospective cohort, 139 women, 12 months. PubMed 16652274.
- Tamarelle J, et al. Incidence and spontaneous clearance of molecular bacterial vaginosis. Sexually Transmitted Diseases, 2022. Daily-sampling cohort, 100 women, ten weeks. PubMed 35969846.
- Bradshaw CS, et al. Recurrence of bacterial vaginosis, posttreatment sexual activities and hormonal contraceptive use. Clinical Infectious Diseases, 2013. Randomised trial, 450 women, six months. PubMed 23243173.
- Peebles K, et al. Elevated risk of bacterial vaginosis among users of the copper intrauterine device. Clinical Infectious Diseases, 2021. Prospective cohort, 2,585 women. PubMed 32505132.
- Vodstrcil LA, et al. Male-partner treatment and recurrence of bacterial vaginosis. New England Journal of Medicine, 2025. Open-label randomised trial, 164 couples; publicly funded. PubMed 40043236.
- NHS. Bacterial vaginosis. Page last reviewed 19 June 2026. nhs.uk/conditions/bacterial-vaginosis.
- Chieng WK, et al. Probiotics to reduce the recurrence of bacterial vaginosis in women. Frontiers in Nutrition, 2022. Systematic review and meta-analysis, ten randomised trials, 1,234 women. PubMed 36204368.
- O'Hanlon DE, et al. Vaginal pH measured in vivo: lactobacilli determine pH and lactic acid concentration. BMC Microbiology, 2019. Observational study, 20 women; two authors work for a company developing vaginal products. PubMed 30642259.
- Amaya-Guio J, et al. Antibiotic treatment for the sexual partners of women with bacterial vaginosis. Cochrane Database of Systematic Reviews, 2016. Cochrane review, seven randomised trials, 1,026 participants; four trials industry-funded. PubMed 27696372.
- Gardella B, et al. Rethinking prevention of recurrent bacterial vaginosis. Journal of Lower Genital Tract Disease, 2026. Network meta-analysis of randomised trials. PubMed 42611724.
- Cohen CR, et al. Randomized trial of a vaginal Lactobacillus crispatus biotherapeutic and recurrence of bacterial vaginosis. New England Journal of Medicine, 2020. Blinded randomised trial, 228 women; publicly funded. PubMed 32402161.
- Hemmerling A, et al. Response to antibiotic treatment predicts the effectiveness of a Lactobacillus crispatus biotherapeutic. Sexually Transmitted Diseases, 2024. Post hoc analysis of the same trial; one author advises the developer. PubMed 38733973.
- Awasthi Y, et al. Lactobacillus vaginal tablets and recurrence of bacterial vaginosis. Probiotics and Antimicrobial Proteins, 2026. Systematic review and meta-analysis, eight randomised trials, 562 women. PubMed 42234392.
- Turner AN, et al. High-dose vitamin D supplementation to reduce recurrence of bacterial vaginosis. American Journal of Obstetrics and Gynecology, 2014. Blinded randomised trial, 118 women; supplement donated by the manufacturer. PubMed 24949544.
Spotted something out of date? Email support@wellgard.co.uk with the page address and the sentence.
General information, not medical advice. See a GP or sexual health clinic for a first episode, any discharge in pregnancy, and whenever treatment has not worked; live cultures are a food supplement, not a treatment.